If approved, donidalorsen would be a first-in-class RNA-targeted medicine for hereditary angioedema. The agency’s goal date ...

Tonix is a fully integrated biopharmaceutical company focused on transforming therapies for pain management and modernizing solutions for public health challenges. Tonix's development portfolio is ...

CHATHAM, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a ...

Nevertheless, rOC43-CoV2-S is a totally novel human coronavirus, and this raises significant concerns. Second, unlike SARS-CoV-2, HCoV-OC43 (and rOC43-CoV2-S) possesses an additional surface ...